These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 16678654)

  • 21. [Hepatic carcinogenesis: prevalent role of hepatitis C virus?].
    Oberti F
    Gastroenterol Clin Biol; 1994; 18(4):394-6. PubMed ID: 7958666
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kuzuya T; Nonogaki K; Shimizu J
    J Gastroenterol Hepatol; 2005 Jun; 20(6):963-5. PubMed ID: 15946154
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatocellular carcinoma and viral cirrhosis.
    Gentilini P; Melani L; Riccardi D; Casini Raggi V; Romanelli RG
    Hepatology; 1994 Sep; 20(3):764-5. PubMed ID: 8076933
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic liver diseases and hepatocellular carcinoma].
    Dtsch Med Wochenschr; 1994 Mar; 119(12):443. PubMed ID: 8143566
    [No Abstract]   [Full Text] [Related]  

  • 25. HCC surveillance: who is the target population?
    Bruix J; Llovet JM
    Hepatology; 2003 Mar; 37(3):507-9. PubMed ID: 12601346
    [No Abstract]   [Full Text] [Related]  

  • 26. Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts.
    Ikeda K; Arase Y; Saitoh S; Kobayashi M; Someya T; Hosaka T; Akuta N; Suzuki Y; Suzuki F; Sezaki H; Kumada H; Tanaka A; Harada H
    J Hepatol; 2006 Jun; 44(6):1089-97. PubMed ID: 16618514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk factors for development of hepatocellular carcinoma in patients with liver cirrhosis associated with hepatitis C virus].
    Matsushita E; Unoura M; Kaneko S; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):727-30. PubMed ID: 7563864
    [No Abstract]   [Full Text] [Related]  

  • 28. [Screening for hepatocellular carcinoma in cirrhotic patients].
    Beaugrand M
    Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B92-4. PubMed ID: 10891771
    [No Abstract]   [Full Text] [Related]  

  • 29. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.
    McGinnis KA; Fultz SL; Skanderson M; Conigliaro J; Bryant K; Justice AC
    J Clin Oncol; 2006 Nov; 24(31):5005-9. PubMed ID: 17075119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incidence of hepatocellular carcinomas in liver cirrhosis].
    Lehmann FG; Martini GA
    Verh Dtsch Ges Inn Med; 1975; 81():1384-7. PubMed ID: 179239
    [No Abstract]   [Full Text] [Related]  

  • 32. [High risk group of patients with hepatitis C virus infection developing hepatocellular carcinoma].
    Yokosuka O; Omata M
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1975-9. PubMed ID: 8586916
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatocellular carcinoma and cirrhosis in Thailand: etiologic considerations of underlying cirrhosis.
    Suwangool P
    J Med Assoc Thai; 1980 May; 63(5):245-9. PubMed ID: 6248611
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients].
    Tarao K; Ohkawa S; Tamai S; Shimizu A
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):740-5. PubMed ID: 7563867
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.
    Sangiovanni A; Iavarone M
    Hepatology; 2008 Jan; 47(1):357; author reply 357-8. PubMed ID: 18161732
    [No Abstract]   [Full Text] [Related]  

  • 36. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
    Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].
    Tarao K; Shimizu A; Okawa S; Tamai S
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1985-91. PubMed ID: 8586918
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis C virus genotype 1b and risk of hepatocellular carcinoma.
    Romeo R; Rumi MG; Del Ninno E; Colombo M
    Hepatology; 1997 Oct; 26(4):1077. PubMed ID: 9328339
    [No Abstract]   [Full Text] [Related]  

  • 39. [Steatosis and hepatitis C].
    Testino G
    Recenti Prog Med; 2005 Dec; 96(12):621-33; quiz 654. PubMed ID: 16496750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
    Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.